These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 23143437)
1. Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines. Prabowo SA; Gröschel MI; Schmidt ED; Skrahina A; Mihaescu T; Hastürk S; Mitrofanov R; Pimkina E; Visontai I; de Jong B; Stanford JL; Cardona PJ; Kaufmann SH; van der Werf TS Med Microbiol Immunol; 2013 Apr; 202(2):95-104. PubMed ID: 23143437 [TBL] [Abstract][Full Text] [Related]
2. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Lange C; Abubakar I; Alffenaar JW; Bothamley G; Caminero JA; Carvalho AC; Chang KC; Codecasa L; Correia A; Crudu V; Davies P; Dedicoat M; Drobniewski F; Duarte R; Ehlers C; Erkens C; Goletti D; Günther G; Ibraim E; Kampmann B; Kuksa L; de Lange W; van Leth F; van Lunzen J; Matteelli A; Menzies D; Monedero I; Richter E; Rüsch-Gerdes S; Sandgren A; Scardigli A; Skrahina A; Tortoli E; Volchenkov G; Wagner D; van der Werf MJ; Williams B; Yew WW; Zellweger JP; Cirillo DM; Eur Respir J; 2014 Jul; 44(1):23-63. PubMed ID: 24659544 [TBL] [Abstract][Full Text] [Related]
3. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination. Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC Front Immunol; 2020; 11():680. PubMed ID: 32411131 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]
8. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis. Okada M; Kita Y; Hashimoto S; Nakatani H; Nishimastu S; Kioka Y; Takami Y Hum Vaccin Immunother; 2017 Feb; 13(2):298-305. PubMed ID: 27960629 [TBL] [Abstract][Full Text] [Related]
9. Drug-resistant TB: deadly, costly and in need of a vaccine. Manjelievskaia J; Erck D; Piracha S; Schrager L Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):186-91. PubMed ID: 26884499 [TBL] [Abstract][Full Text] [Related]
10. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool. Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438 [TBL] [Abstract][Full Text] [Related]
11. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439 [TBL] [Abstract][Full Text] [Related]
14. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development. Chae H; Shin SJ J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826 [TBL] [Abstract][Full Text] [Related]
15. [Annual progress of immunotherapy for tuberculosis in 2023]. Ke H; Fan L Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):371-375. PubMed ID: 38599815 [TBL] [Abstract][Full Text] [Related]
16. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB). Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909 [TBL] [Abstract][Full Text] [Related]
17. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Multidrug-resistant Tuberculosis. Rumende CM Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169 [TBL] [Abstract][Full Text] [Related]
19. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs. Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251 [TBL] [Abstract][Full Text] [Related]